全文获取类型
收费全文 | 2522篇 |
免费 | 117篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 111篇 |
妇产科学 | 59篇 |
基础医学 | 280篇 |
口腔科学 | 13篇 |
临床医学 | 139篇 |
内科学 | 695篇 |
皮肤病学 | 31篇 |
神经病学 | 273篇 |
特种医学 | 82篇 |
外国民族医学 | 2篇 |
外科学 | 343篇 |
综合类 | 7篇 |
预防医学 | 181篇 |
眼科学 | 28篇 |
药学 | 193篇 |
中国医学 | 2篇 |
肿瘤学 | 182篇 |
出版年
2023年 | 10篇 |
2022年 | 18篇 |
2021年 | 47篇 |
2020年 | 29篇 |
2019年 | 59篇 |
2018年 | 60篇 |
2017年 | 52篇 |
2016年 | 34篇 |
2015年 | 44篇 |
2014年 | 63篇 |
2013年 | 96篇 |
2012年 | 162篇 |
2011年 | 145篇 |
2010年 | 85篇 |
2009年 | 90篇 |
2008年 | 113篇 |
2007年 | 142篇 |
2006年 | 109篇 |
2005年 | 114篇 |
2004年 | 108篇 |
2003年 | 108篇 |
2002年 | 102篇 |
2001年 | 89篇 |
2000年 | 95篇 |
1999年 | 81篇 |
1998年 | 25篇 |
1997年 | 23篇 |
1996年 | 20篇 |
1995年 | 12篇 |
1992年 | 42篇 |
1991年 | 35篇 |
1990年 | 42篇 |
1989年 | 27篇 |
1988年 | 25篇 |
1987年 | 31篇 |
1986年 | 26篇 |
1985年 | 25篇 |
1984年 | 25篇 |
1983年 | 23篇 |
1982年 | 14篇 |
1979年 | 15篇 |
1978年 | 10篇 |
1977年 | 12篇 |
1975年 | 9篇 |
1974年 | 18篇 |
1973年 | 11篇 |
1972年 | 21篇 |
1971年 | 12篇 |
1969年 | 11篇 |
1967年 | 13篇 |
排序方式: 共有2643条查询结果,搜索用时 31 毫秒
1.
2.
3.
Eric T. Stoopler DMD res Pinto DMD Faizan Alawi DDS Sree Raghavendra DMD Ricardo Boyce Jr. DDS David Porter MD Thomas P. Sollecito DMD 《Special care in dentistry》2004,24(2):65-69
Acute myelogenous leukemia (AMU is a hematologic disorder that is characterized by an abnormal proliferation of immature myeloid cells. Granulocytic sarcomas are clusters of leukemic myeloid cells that may develop as a result of AML. Oral manifestations of AML are common and often involve enlargements of the gingiva and/or mucosal tissue from direct leukemia cell infiltration. We describe the case history of a 50-year-old man who had an ulcera-tive lesion of the oral mucosa that was determined to be a granulocytic sarcoma of AML-M0 subtype. The combination of both the subtype and clinical presentation of the leukemia makes this presentation unusual, and to the best of our knowledge, of a type that has not been previously reported in the literature. 相似文献
4.
J Béres T Tauszik M Horányi I Pazonyi J Szelényi Z Hollán G Flatz 《Orvosi hetilap》1992,133(30):1869-1873
In 1984 a late malaria endemic area, called Bodrogk?z was studied. This was a reexamination of the population genetic work performed by Walter, Nemeskéri. In six villages of Bodrogk?z 328 persons were tested for AB0, Rh blood groups, haptoglobins, haemoglobin concentration, haematocrit, erythrocyte amount, the MCV, the MCH and the G-6-PD were analyzed. The quantitative determination of HbF and HbA2, red cell osmotic resistance and thalassemia were measured as well. Thalassemia heterozygote carriers and an increased level of HbF were revealed. The frequency of G-6-PD deficiency was 0.39%. In Bodrogk?z the frequencies of AB0, Rh and haptoglobin types were similar in the present and all previous studies. The background of this similarity might be the genetic similarity between two following generations. On the basis of these facts, the Hb0 Arab and partially DNA work we suggested an alternative hypothesis that these mutant genes got into Bodrogk?z by the rather later migration than with ancient Hungarian people during the period of conquest of Hungary. 相似文献
5.
5-Fluorouracil, 5-fluorouridine (FUrd), 5-fluoro-2'-deoxyuridine (FdUrd), 5-fluorocytidine (FCyd), 5-fluoro-2'-deoxycytidine (FdCyd), 5-trifluoro-2'-deoxythymidine (F3dThd), and the 5'-monophosphates and 3',5'-cyclic monophosphates thereof were found to inhibit thymidine kinase-deficient (TK-) mutant strains of herpes simplex virus (HSV) at a much lower concentration than the wild-type (TK+) HSV strains. Other 5-substituted 2'-deoxyuridines that have previously been recognized as potent thymidylate synthase inhibitors behaved in a similar fashion. The activity of FdUrd, FdCyd, F3dThd, and their 3',5'-cyclic monophosphates against TK-HSV was readily reversed by 2'-deoxythymidine (dThd) but not by 2'-deoxyuridine (dUrd). These compounds also inhibited the incorporation of [6-3H]dUrd into DNA at a concentration which was up to 5 orders of magnitude lower than the concentration at which the incorporation of [methyl-3H] dThd was inhibited. Thus, while not being a target for the well established anti-HSV compounds in TK+HSV-infected cells, thymidylate synthase appears to be an important target in TK-HSV-infected cells. In addition to dTMP synthase, TK-HSV-infected cells appear to reveal other therapeutically exploitable targets such as OMP decarboxylase (towards pyrazofurin), CTP synthase (towards carbodine and its cyclopentenyl analogue), dihydrofolate reductase (towards methotrexate), and S-adenosylhomocysteine hydrolase (towards neplanocins). 相似文献
6.
7.
J. M. Dolo N. Lecerf V. Mihajlovic C. Falgures J. J. Bahain 《Applied radiation and isotopes》1996,47(11-12)
A very precise dosimetry of a field of artificial irradiation is essential to estimate an accurate ESR Equivalent Dose (ED) in archaeology and geology. Archaeological powder samples and one sample of DL-alanine powder as control were prepared by IPH. Some alanine dosimeters of LMRI, constituted of L-alanine pellets, were joined to the IPH samples and together, irradiated in boxes using panoramic 60Co source under different experimental conditions. The LMRI had in charge the control of the process of irradiation and the measurement of each absorbed dose and dose rate delivered to the different series of boxes. This study consists in the evaluation of the distribution of dose on the samples. The ESR measurements made by the two laboratories were analysed and then compared. These experiments showed a significant gradient in the absorbed dose delivered to each LMRI dosimeter. The dispersion in each box was easily observable. However, a good agreement between the dosimeters and the alanine powder was observed in a same box. 相似文献
8.
Egidio L. Romano res Soyano Ramón F. Montaño Murray Ratcliffe Marilyn Olson Guillermo Suarez Nelly Martínez and Geoffrey Worstey 《Vox sanguinis》1994,66(3):194-199
Thirteen infants, 10 with A-O and 3 with B-O hemolytic disease of the newborn (ABO-HDN), were treated with synthetic A or B blood group trisaccharides (ATS, BTS) which cause dissociation of maternal antibody bound to infant red cells. The clinical outcome was compared with that of a control group of 21 infants treated with phototherapy during the preceding year. Exchange transfusion was required in 2 out of 13 infants in the experimental group and in 7 in the control group. A randomized prospective controlled study is necessary to confirm these results. 相似文献
9.
D Cowen P Richaud G Marit P Cony-Makhoul R Trouette C Fabères J Reiffers 《Bone marrow transplantation》1992,10(6):515-519
In our institution, total body irradiation (TBI) is performed by means of a sweeping beam technique. Toxicity of the procedure was evaluated according to the only grading system designed for high dose chemoradiotherapy. One hundred patients undergoing TBI and conditioned with a standard cyclophosphamide regimen before BMT were evaluated. Regimen-related toxicity was graded according to the Seattle transplantation toxicity system, from 0 to IV (fatal toxicity), in eight organs on days 0, 7, 14, 28 and 100 for lungs. Eighteen patients did not develop any toxicity. Grades III, IV toxicities were uncommon (9%) and were not influenced by dose of TBI, GVHD prophylaxis, disease status and allogenicity although no grade IV toxicity was observed among autologous marrow recipients. However, grade II toxicity was more common in patients receiving allogeneic vs autologous grafts (p < 0.01) because of increased mucosal (p = 0.002) and liver (p = 0.12) toxicities. Renal toxicity was unevaluable. When cumulative toxicity was equal or higher than 4, day 100 survival was worse (p = 0.05). These data confirm the safety of our TBI procedure and the validity of the grading system except for renal toxicity. We suggest that a more aggressive conditioning regimen may be tolerated by patients receiving autologous grafts. 相似文献
10.
Long-Term Clinical Outcomes Following Treatment of Actinic Keratosis with Imiquimod 5% Cream 总被引:2,自引:0,他引:2
Lee Peter K. MD PhD Harwell William B. MD † Loven Keith H. MD ‡ Phillips Tania J. MD § Whiting David A. MD res Kara L. MS # Lee James H. MD PhD # 《Dermatologic surgery》2005,31(6):659-664
BACKGROUND: The results from four phase III, randomized, vehicle-controlled studies showed that imiquimod 5% cream (imiquimod) was safe and effective in the treatment of actinic keratosis (AK). Patients applied imiquimod or vehicle cream to AK lesions on the face or balding scalp, dosing three times per week or two times per week for 16 weeks. OBJECTIVE: To obtain long-term safety follow-up data and estimate AK recurrence in patients who completely cleared their AK lesions in the treatment area at the 8-week post-treatment visit in the phase III studies. METHODS: One hundred forty-six patients from 30 study centers in the United States were evaluated for clinical evidence of AK, and safety data were collected. RESULTS: After a median follow-up period of 16 months, 24.7% (19 of 77) of the patients administered imiquimod three times per week and 42.6% (23 of 54) of the patients administered imiquimod two times per week had a recurrence of AK (the appearance of at least one AK lesion) in the original treatment area. The median number of AK lesions present was one lesion for both patients receiving imiquimod three times and those receiving imiquimod two times per week compared with a median of six lesions at baseline in the combined three times per week and two times per week phase III studies. There were no long-term safety issues, and the skin quality seen in the imiquimod-treated patients at the end of the phase III studies was maintained. CONCLUSION: One and a half years following treatment, imiquimod continued to provide a long-term clinical benefit in a majority of patients who experienced complete clearance of their AK lesions. 相似文献